Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ACELRX PHARMACEUTICALS INC (ACRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Royalty revenue  2.85.42.32.28.017.419.35.2
            Royalty revenue growth  -48.0%136.6%6.4%-73.1%-53.9%-9.9%269.2%-82.3%
Operating costs and expenses:          
Research and development  4.14.04.713.119.421.422.524.5
Selling, general and administrative  30.936.345.020.816.6   
    Total operating costs and expenses  38.846.456.537.946.761.641.042.9
   
    Loss from operations          
Other income (expense):          
Interest expense  -2.3-3.3-2.5-2.2-3.3-2.8-3.0-2.6
Interest income and other (expense) income, net  -0.1-0.6-2.2-1.1-0.5-0.9-1.7-6.9
    Total other income (expense)  0.90.61.0-11.4-13.5-11.2-3.74.3
   
    Net income (loss) before income taxes          
Provision for income taxes  0.00.00.00.0-0.70.00.8 
    Net income (loss)  -35.1-40.4-53.2-47.1-51.5-43.2-24.4-33.4
   
    Net income (loss) attributable to Common Shareholders, basic  ($0.29)($0.47)($0.67)($0.81)($1.10)($0.95)($0.60)($0.91)
   
Basic earnings (loss) per share          
    Net income (loss) per share (in dollars per share)  ($0.29)($0.47)($0.67)($0.81)($1.10)($0.95)($0.55)($0.77)
   
Diluted earnings (loss) per share          
    Net income (loss) per share (in dollars per share)  ($0.29)($0.47)($0.67)($0.81)($1.10)($0.95)($0.60)($0.91)
   
Shares used in computing net income  119.985.379.258.446.945.344.343.4
Shares used in computing net income  119.985.379.258.446.945.344.544.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy